Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by:

Bayer

ClinicalTrials.gov Identifier:

NCT00692770

First received: June 5, 2008

Last updated: April 8, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2020
Estimated Primary Completion Date:	May 2014 (Final data collection date for primary outcome measure)

No publications provided by Bayer

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):